CPC A61K 38/1709 (2013.01) [A61K 9/0019 (2013.01); A61K 31/662 (2013.01); A61K 31/664 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/55 (2013.01); A61P 13/12 (2018.01); A61P 29/00 (2018.01); A61P 35/04 (2018.01); A61P 37/06 (2018.01); A61P 43/00 (2018.01); C07C 323/58 (2013.01); C07F 9/302 (2013.01); C07K 16/40 (2013.01); C12N 9/485 (2013.01); C12Y 304/13019 (2013.01); C07K 2317/76 (2013.01)] | 20 Claims |
1. A method for treating or preventing (i) acute kidney injury or (ii) ischemia-reperfusion injury in a subject in need thereof, comprising administering an effective amount of a compound that binds to DPEP-1 to the subject in the absence of an antibiotic or nephrotoxic compound, thereby treating or preventing the acute kidney injury or ischemia reperfusion injury.
|